UnknownNot Applicable

Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse

China1,000 participantsStarted 2019-06-24

Plain-language summary

This clinical trial aims to evaluate the efficacy and safety of long needle and short needle in the treatment of internal hemorrhoids and rectal prolapse through CAES (Cap-assisted endoscopic sclerotherapy).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with internal hemorrhoids and rectal prolapse, combined with external hemorrhoids or without external hemorrhoids.
✓. Patients with bowel preparation.

Exclusion criteria

✕. History of anoscopic/endoscopic sclerotherapy.
✕. Patients with acute thrombotic external hemorrhoids.
✕. Patients with serious internal hemorrhoids of grade IV.
✕. Patients with anal stenosis, anal fissure, fistula, fecal incontinence, ulcerative colitis, Crohn's disease.
✕. Patients with acute diarrhea in the past 24 hours.
✕. Hypertensive patients with uncontrolled blood pressure, patients with cerebrovascular accident and obvious bleeding tendency, pregnant women, mental disorders and decompensated cirrhosis.

What they're measuring

Recurrence rate

Timeframe: 24 weeks

Trial details

NCT IDNCT03917056

SponsorThe Second Hospital of Nanjing Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-01

Contact for this trial

Faming Zhang, MD,PhD

86-25-58509883 fzhang@njmu.edu.cn

View on ClinicalTrials.gov More Internal Hemorrhoid trials